Home  >  Products  >  APOBEC1 (apolipoprotein B mRNA editing enzyme, catalytic polypeptide 1) Blocking Peptide (the N terminal of protein) (100ug)
APOBEC1 (apolipoprotein B mRNA editing enzyme, catalytic polypeptide 1) Blocking Peptide (the N terminal of protein) (100ug)

APOBEC1 (apolipoprotein B mRNA editing enzyme, catalytic polypeptide 1) Blocking Peptide (the N terminal of protein) (100ug)


Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-APOBEC1 antibody (Catalogue #: ARP40371_P050) made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Presku: AAP40371
Size: 100 ug
Weight: 28kDa
Gene: 339
Format: Lyophilized powder
Target: APOBEC1 is a member of the cytidine deaminase enzyme family. The protein forms a multiple-protein editing holoenzyme with APOBEC1 complementation factor (ACF) and APOBEC1 stimulating protein (ASP). This holoenzyme is involved in the editing of C-to-U nucleotide bases in apolipoprotein B and neurofibromatosis-1 mRNAs.This gene encodes a member of the cytidine deaminase enzyme family. The encoded protein forms a multiple-protein editing holoenzyme with APOBEC1 complementation factor (ACF) and APOBEC1 stimulating protein (ASP). This holoenzyme is involved in the editing of C-to-U nucleotide bases in apolipoprotein B and neurofibromatosis-1 mRNAs. Publication Note: This RefSeq record includes a subset of the publications that are available for this gene. Please see the Entrez Gene record to access additional publications.
Alternative names: APOBEC-1; BEDP; CDAR1; HEPR